Home
About
Overview
Sharing Data
ORCID
Help
History (29)
HEPATOCYTE REMODELING BY HEPATITIS C VIRUS
Principal Investigator
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients with Cancer.
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol. 1996 Apr; 14(4):1320-6.
View in:
PubMed
subject areas
Adult
Aged
Female
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Molecular Sequence Data
Myelodysplastic Syndromes
Oligodeoxyribonucleotides, Antisense
Oligonucleotides, Antisense
Thionucleotides
Treatment Outcome
authors with profiles
Michael Bishop